RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 103 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $761,000 | -75.4% | 30,567 | -79.8% | 0.00% | -100.0% |
| Q2 2021 | $3,090,000 | +5730.2% | 151,446 | +6046.3% | 0.00% | – |
| Q1 2021 | $53,000 | -75.0% | 2,464 | -61.6% | 0.00% | – |
| Q4 2020 | $212,000 | +430.0% | 6,418 | +263.6% | 0.00% | – |
| Q3 2020 | $40,000 | -32.2% | 1,765 | -34.4% | 0.00% | – |
| Q2 2020 | $59,000 | -30.6% | 2,689 | -27.3% | 0.00% | – |
| Q4 2019 | $85,000 | +93.2% | 3,697 | +83.5% | 0.00% | – |
| Q3 2019 | $44,000 | +2.3% | 2,015 | +3.7% | 0.00% | – |
| Q2 2019 | $43,000 | – | 1,943 | +194200.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 1 | -99.5% | 0.00% | – |
| Q4 2018 | $6,000 | +100.0% | 216 | +105.7% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 105 | +20.7% | 0.00% | – |
| Q2 2018 | $3,000 | – | 87 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
| NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
| RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
| Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
| Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
| Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
| Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
| ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
| Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
| Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |